Inserm Transfert
Paris, Île-de-Franceinserm-transfert.fr
Overview
Inserm Transfert is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding . The company supports Inserm research units and researchers in the process undertaken to create value from their work . Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Step Pharma | Oct 2025 | Series C | Co-investor |
| Step Pharma | Oct 2023 | Series C | Co-investor |
| POLYGON Therapeutics | Sep 2022 | Pre Seed | Co-investor |
| PulseSight Therapeutics | Jan 2020 | Series B | Co-investor |
| PulseSight Biosciences | Jan 2020 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
